- Home
- KAI vs APLS Comparison
KAI vs APLS Comparison
Compare KAI & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAI
- APLS
- Stock Information
- Founded
- KAI 1991
- APLS 2009
- Country
- KAI United States
- APLS United States
- Employees
- KAI N/A
- APLS N/A
- Industry
- KAI Industrial Machinery/Components
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- KAI Industrials
- APLS Health Care
- Exchange
- KAI Nasdaq
- APLS Nasdaq
- Market Cap
- KAI 3.8B
- APLS 4.4B
- IPO Year
- KAI N/A
- APLS 2017
- Fundamental
- Price
- KAI $408.13
- APLS $27.75
- Analyst Decision
- KAI Buy
- APLS Buy
- Analyst Count
- KAI 2
- APLS 19
- Target Price
- KAI $330.00
- APLS $49.89
- AVG Volume (30 Days)
- KAI 76.4K
- APLS 4.0M
- Earning Date
- KAI 10-29-2024
- APLS 11-05-2024
- Dividend Yield
- KAI 0.32%
- APLS N/A
- EPS Growth
- KAI N/A
- APLS N/A
- EPS
- KAI 9.77
- APLS N/A
- Revenue
- KAI $1,034,032,999.00
- APLS $715,216,000.00
- Revenue This Year
- KAI $11.10
- APLS $95.59
- Revenue Next Year
- KAI $3.48
- APLS $13.77
- P/E Ratio
- KAI $41.77
- APLS N/A
- Revenue Growth
- KAI 8.72
- APLS 162.10
- 52 Week Low
- KAI $249.51
- APLS $24.34
- 52 Week High
- KAI $422.54
- APLS $73.80
- Technical
- Relative Strength Index (RSI)
- KAI 74.56
- APLS 47.09
- Support Level
- KAI $384.21
- APLS $25.76
- Resistance Level
- KAI $400.63
- APLS $30.80
- Average True Range (ATR)
- KAI 11.46
- APLS 1.84
- MACD
- KAI 1.46
- APLS 0.04
- Stochastic Oscillator
- KAI 81.97
- APLS 52.79
About KAI Kadant Inc
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence with sizable revenue from the U.S., Europe, Asia, and Canada.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.